Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A U.S. Post-Approval Study of the SYNERGYTM Everolimus-Eluting Platinum Chromium Coronary Stent System Evaluating the SYNERGY XLV (MEGATRON) Stent System

NCT04807439 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT04807439
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04807439 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A U.S. Post-Approval Study of the SYNERGYTM Everolimus-Eluting Platinum Chromium Coronary Stent System Evaluating the SYNERGY XLV (MEGATRON) Stent System
Lead sponsor
Boston Scientific Corporation
Phase
Observational
Overall status
Completed
Start date
April 14, 2021
Completion date
August 18, 2023
Enrollment
100 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, cardiovascular diseases, coronary artery disease, heart diseases, coronary